期刊文献+

氯胺酮相关性泌尿系统损害的研究进展 被引量:3

原文传递
导出
摘要 近年来氯胺酮相关性疾病在我国呈上升趋势,经济发达地区尤为明显。2007年首次报道氯胺酮对泌尿系统的损害后,人们对其认识逐步加深,但了解仍然不足,现结合相关文献,将其发病机制、临床特点和治疗综述如下,以提高临床医生的认识。
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2012年第8期631-633,共3页 Chinese Journal of Urology
  • 相关文献

参考文献45

  • 1Hijazi Y, Boulieu R. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ket- amine in human liver microsomes. Drug Metab Dispos, 2002, 30: 853- 858.
  • 2Shahani R, Streutker C, Dickson B, et al. Ketamine-associated ulcerative cysti- tis: a new clinical entity. Urology, 2007, 69: 810-812.
  • 3Cottrell A, Warren K, Ayres R, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome. BJU Int, 2008, 102: 1178-1179.
  • 4Chao JY, Shai HA. Duloxetine treatment of long-term ketamlne abuse-related lower urinary tract symptoms: a case report. Gen Hosp Psychiatry, 2010, 32: 647.
  • 5Gregoire MC, MacLellan DL, Finley GA. A pediatric case of ketamine-associated cystitis. Urology, 2005, 71: 1232-1233.
  • 6Mason K, Cottrell AM, Corrigan AG, et al. Ketamine-associated lower urinary tract destruction: a new radiological challenge. Clin Radiol, 2010, 65: 795- 800.
  • 7Chu PS, Kwok SC, Lam KM, et al. 'Street ketamine'-associated bladder dysfunction: a report of ten cases. Hong Kong Med J, 2007, 13: 311- 313.
  • 8Oxley JD, Cottrell AM, Adams S, et al. Ketamine cystitis as a mimic of carcino- ma in situ. Histopathology, 2009, 55: 705-708.
  • 9Curtis FG, Vianna PT, Viero RM, et al. Dexmedetomidine and S( + )-ketamine in ischemia and reperfusion injury in the rat kidney. Acta Cir Bras, 2011, 26: 202- 206.
  • 10Chiew YW, Yang CS. Disabling frequent urination in a young adult. Ketamine-as- sociated ulcerative cystitis. Kidney Int, 2009, 76: 123-124.

二级参考文献36

  • 1沈杰,范乃建.新型毒品氯胺酮(K粉)的毒理作用、滥用趋势及危害[J].云南警官学院学报,2004(3):34-35. 被引量:14
  • 2王亮,陈昭颉,王庆堂,曹文峰,刘祥丹,陈卫国,汪俊超.肝素膀胱灌注治疗间质性膀胱炎[J].中华泌尿外科杂志,2004,25(9):625-626. 被引量:34
  • 3丘志馨.氯胺酮的药理作用及滥用问题探讨[J].广东公安科技,2006,14(1):14-18. 被引量:15
  • 4Siegel RK. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. NIDA Res Monogr, 1978:119-147.
  • 5Agarwal A, Gupta D, Kumar M, et al. Ketamine for treatment of catheter related bladder discomfort: a prospective, randomized, placebo controlled and double blind study. Br J Anaesth,2006,96:587-589.
  • 6Chu PS, Kwok SC, Lam KM, et al. Street ketamine-associated bladder dysfunction:a report of ten cases. Hong Kong Med J,2007,13:311 313.
  • 7Shahani R, Streutker C, Dickson B, et al. Ketamine-associated ulcerative cystitis: a new clinical entity. Urology, 2007,69 : 810-812.
  • 8Chu P S, Kwok S C, Lain K M, et al. "Street ketamine"-associated bladder dysfunction: a report of ten cases [J]. Hong Kong Med J, 2007,13(4) : 311-313.
  • 9Chu P S, Ma W K, Wong S C, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome [J]? Br J Urol, 2008,102( 11 ) : 1616-1622.
  • 10Chu PS,Kwok SC,Lam KM,et al.Street ketamine-associated bladder dysfunction:a reprort of ten cases.Hong Kong Med J,2007,13:311-313.

共引文献91

同被引文献50

  • 1王亮,陈昭颉,王庆堂,曹文峰,刘祥丹,陈卫国,汪俊超.肝素膀胱灌注治疗间质性膀胱炎[J].中华泌尿外科杂志,2004,25(9):625-626. 被引量:34
  • 2Brady C M,Apostolidis A,Yiangou Y,et al.P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin[J].Eur Urol,2004,46(2):247-253.
  • 3Meng E,Chang H Y,Chang S Y,et al.Involvement of purinergic neurotransmission in ketamine induced bladder dysfunction[J].J Urol,2011,186(3):1134-1141.
  • 4Ferguson D R,Kennedy I,Burton T J.ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes--apossible sensory mechanism[J]?J Physiol,1997,505(Pt 2):503-511.
  • 5Cockayne D A,Hamilton S G,Zhu Q M,et al.Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice[J].Nature,2000,407(6807):1011-1015.
  • 6Andersson K E.Bladder activation:afferent mechanisms[J].Urology,2002,59(5Suppl 1):43-50.
  • 7Abrams P, Cardozo L, Fall M,et al. The standardisation of termi- nology of lower urinary tract function : report from the standardisa- tion subcommittee of the International continence society [ J ]. Neurourol Uro - dyn,2002,21 (12) : 167 - 178.
  • 8Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States [ J ]. World J Urol,2003,20(6) :327 - 336.
  • 9Curhan GC, Speizer FE, Hunter DJ, et al. Epidemiology of intersti- tial cystitis : a population based study [ J ]. J Urol, 1999,161 ( 2 ) : 549 - 552.
  • 10Lam S, Hilas O. Pharmacologic management of overactive bladder [ J ]. Clinical Interventions in Aging,2007,2 ( 3 ) :337 - 345.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部